Related posts
3 Best U.S. Healthcare ETFsThis summary was created by AI, based on 8 opinions in the last 12 months.
The Healthcare Leaders Income ETF (HHL-T) has been recognized as a consistent performer in the market, boasting stable monthly distributions over the past decade. Experts acknowledge its equity risk and mild volatility, yet they highlight its appeal as a source of reliable income, particularly for investors focusing on dividends. This ETF employs a covered call strategy, enhancing yield but limiting capital appreciation potential, making it more suitable for income-oriented investors rather than those seeking significant growth. While the healthcare sector faces challenges amid changing political landscapes, the ETF maintains a robust portfolio of large-cap healthcare companies. Experts recommend it as a component within a diversified portfolio, albeit with caution regarding the potential effects of return of capital on investors.
A covered call ETF so it provides extra income. He's recommended it before.
The unhedged stock. Is covered call, boosting yield. Healthcare stocks have sold off, like Eli Lilly, though ISRG has done well. Is a lot of change in healthcare amid the change in presidents. So, this sector is sadly on the back burner. If you hold it, you get paid a good dividend as you wait.
A good product that can be held. Would recommend as a portion of portfolio. Not a capital appreciation strategy - covered call reduces ability for share to appreciate.
Great option for income oriented investors. However, would recommend diversifying with other names in portfolio. Overall direction of healthcare sector is strong.
Good for healthcare exposure with dividend. Won't get high capital gains. But is a reliable product.
Blue-chip basket of US healthcare names. Covered calls and leverage. Covered calls trade potential upside for potential income. If investor's ACB has gone down, could be because of return of capital.
The Harvest covered call ETFs start well, but then flatline. So, he has sold all his Harvest ETFs.
Healthcare sector lagging in the market, and is due for an increase in value. Very large companies with tailwind in aging population/demand for healthcare. Covered call strategy adds to yield. Good option for investors going forward.
It was strictly a yield play when interest rates were so low. He has only a small position. Growth in the ETF can be somewhat restrained by the covered call structure. It's a tradeoff between yield and growth. He's still bullish on the healthcare sector, the demographics are beautiful.
Very good for healthcare exposure.
Actively managed with good performance.
High dividend yield (~10%).
Good for long term investors.
Healthcare Leaders Income ETF is a Canadian stock, trading under the symbol HHL-T on the Toronto Stock Exchange (HHL-CT). It is usually referred to as TSX:HHL or HHL-T
In the last year, 6 stock analysts published opinions about HHL-T. 3 analysts recommended to BUY the stock. 1 analyst recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Healthcare Leaders Income ETF.
Healthcare Leaders Income ETF was recommended as a Top Pick by on . Read the latest stock experts ratings for Healthcare Leaders Income ETF.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
6 stock analysts on Stockchase covered Healthcare Leaders Income ETF In the last year. It is a trending stock that is worth watching.
On 2025-02-20, Healthcare Leaders Income ETF (HHL-T) stock closed at a price of $8.055.
It has had the same distribution for the past 10 years and is one of the top performers in the market. It has equity risk with some volatility but pays a consistent monthly distribution. Holds 20 large cap companies with maybe only a couple of changes per year.